 |
 |

Serum Cholesterol Level and Hepatoma
Min-Chun Chen, MD, MPH;
Michael R. Mullane, MD;
Thomas E. Lad, MD
University of Illinois Hospital and Clinics Chicago West Side Veterans Administration Medical Center Chicago, Ill
JAMA. 1990;264(16):2071-2072.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
To the Editor.—
In their interesting and important study, Winawer and colleagues1 conclude that individuals in whom colorectal cancer develops share the same level of serum cholesterol as the general population initially but demonstrate a decline in serum cholesterol level prior to the diagnosis of cancer. As clinicians, we believe that the other intriguing association between serum cholesterol level and gastrointestinal malignancy is the development of hypercholesterolemia in patients with hepatoma as demonstrated by one of our patients seen recently at West Side Veterans Administration Medical Center.
Report of a Case.—
In September 1988, a 34-year-old black man had a serum cholesterol level of 5.00 mmol/L (193 mg/dL) (normal level, 3.10 to 5.70 mmol/L [120 to 220 mg/dL]) documented as part of his routine serum biochemistry tests. There was no history of familial hypercholesterolemia. He occasionally drank alcohol excessively but otherwise had been healthy until August 1989, when he
. . . [Full Text PDF of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|